• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

消除潜伏 HIV-1 并随后实现 HIV-1 治愈的当前策略综述。

A Review of Current Strategies Towards the Elimination of Latent HIV-1 and Subsequent HIV-1 Cure.

机构信息

Centre for Microbiology Research-Kenya medical Research Institute, P.O Box 54840-00200, Nairobi, Kenya.

Centre for Virology Research-Kenya medical Research Institute, P.O Box 54840-00200, Nairobi, Kenya.

出版信息

Curr HIV Res. 2021;19(1):14-26. doi: 10.2174/1570162X18999200819172009.

DOI:10.2174/1570162X18999200819172009
PMID:32819259
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8573729/
Abstract

BACKGROUND

During the past 35 years, highly effective ART has saved the lives of millions of people worldwide by suppressing viruses to undetectable levels. However, this does not translate to the absence of viruses in the body as HIV persists in latent reservoirs. Indeed, rebounded HIV has been recently observed in the Mississippi and California infants previously thought to have been cured. Hence, much remains to be learned about HIV latency, and the search for the best strategy to eliminate the reservoir is the direction current research is taking. A systems-level approach that fully recapitulates the dynamics and complexity of HIV-1 latency In vivo and is applicable in human therapy is prudent for HIV eradication to be more feasible.

OBJECTIVES

The main barriers preventing the cure of HIV with antiretroviral therapy have been identified, progress has been made in the understanding of the therapeutic targets to which potentially eradicating drugs could be directed, integrative strategies have been proposed, and clinical trials with various alternatives are underway. The aim of this review is to provide an update on the main advances in HIV eradication, with particular emphasis on the obstacles and the different strategies proposed. The core challenges of each strategy are highlighted and the most promising strategy and new research avenues in HIV eradication strategies are proposed.

METHODS

A systematic literature search of all English-language articles published between 2015 and 2019, was conducted using MEDLINE (PubMed) and Google scholar. Where available, medical subject headings (MeSH) were used as search terms and included: HIV, HIV latency, HIV reservoir, latency reactivation, and HIV cure. Additional search terms consisted of suppression, persistence, establishment, generation, and formation. A total of 250 articles were found using the above search terms. Out of these, 89 relevant articles related to HIV-1 latency establishment and eradication strategies were collected and reviewed, with no limitation of study design. Additional studies (commonly referenced and/or older and more recent articles of significance) were selected from bibliographies and references listed in the primary resources.

RESULTS

In general, when exploring the literature, there are four main strategies heavily researched that provide promising strategies to the elimination of latent HIV: Haematopoietic Stem-Cell Transplantation, Shock and Kill Strategy, Gene-specific transcriptional activation using RNA-guided CRISPR-Cas9 system, and Block and Lock strategy. Most of the studies of these strategies are applicable in vitro, leaving many questions about the extent to which, or if any, these strategies are applicable to complex picture In vivo. However, the success of these strategies at least shows, in part, that HIV-1 can be cured, though some strategies are too invasive and expensive to become a standard of care for all HIV-infected patients.

CONCLUSION

Recent advances hold promise for the ultimate cure of HIV infection. A systems-level approach that fully recapitulates the dynamics and complexity of HIV-1 latency In vivo and applicable in human therapy is prudent for HIV eradication to be more feasible. Future studies aimed at achieving a prolonged HIV remission state are more likely to be successful if they focus on a combination strategy, including the block and kill, and stem cell approaches. These strategies propose a functional cure with minimal toxicity for patients. It is believed that the cure of HIV infection will be attained in the short term if a strategy based on purging the reservoirs is complemented with an aggressive HAART strategy.

摘要

背景

在过去的 35 年中,高效的抗逆转录病毒疗法(ART)通过将病毒抑制到无法检测的水平,挽救了全球数百万人的生命。然而,这并不意味着病毒在体内不存在,因为 HIV 仍然存在于潜伏的储库中。事实上,最近在密西西比州和加利福尼亚州的婴儿中观察到了反弹的 HIV,这些婴儿以前被认为已经治愈。因此,人们对 HIV 潜伏期还有很多需要了解,寻找消除储库的最佳策略是当前研究的方向。一种能够充分再现 HIV-1 潜伏期体内动力学和复杂性的系统水平方法,并且适用于人体治疗,对于实现 HIV 根除更为可行。

目的

确定了阻止 HIV 通过抗逆转录病毒疗法治愈的主要障碍,加深了对潜在根除药物靶向的治疗靶点的理解,提出了综合策略,并正在进行各种替代方案的临床试验。本综述的目的是提供 HIV 根除方面的主要进展更新,特别强调障碍和提出的不同策略。强调了每个策略的核心挑战,并提出了 HIV 根除策略中最有前途的策略和新的研究途径。

方法

对 2015 年至 2019 年间发表的所有英文文章进行了系统的文献检索,使用 MEDLINE(PubMed)和 Google Scholar 进行了检索。如果有可用的医学主题词(MeSH),则将其用作搜索词,并包括:HIV、HIV 潜伏期、HIV 储库、潜伏期再激活和 HIV 治愈。其他搜索词包括抑制、持续存在、建立、产生和形成。使用上述搜索词共找到 250 篇文章。其中,有 89 篇与 HIV-1 潜伏期建立和根除策略相关的文章被收集并进行了综述,对研究设计没有任何限制。从主要资源的参考文献和列出的参考文献中选择了其他研究(通常引用的和更旧的和更重要的文章)。

结果

一般来说,在探索文献时,有四种主要策略受到了广泛研究,为消除潜伏性 HIV 提供了有希望的策略:造血干细胞移植、休克和杀伤策略、使用 RNA 指导的 CRISPR-Cas9 系统进行基因特异性转录激活,以及阻断和锁定策略。这些策略的大多数研究都可在体外进行,这就提出了一个问题,即在多大程度上或是否可以将这些策略应用于体内复杂的情况。然而,这些策略的成功至少表明,HIV-1 可以被治愈,尽管一些策略过于侵入性和昂贵,无法成为所有 HIV 感染患者的标准治疗方法。

结论

最近的进展为 HIV 感染的最终治愈带来了希望。一种能够充分再现 HIV-1 潜伏期体内动力学和复杂性的系统水平方法,并且适用于人体治疗,对于实现 HIV 根除更为可行。如果未来的研究专注于联合策略,包括阻断和杀伤以及干细胞方法,以实现长期的 HIV 缓解状态,那么成功的可能性更大。这些策略为患者提供了一种具有最小毒性的功能性治愈。如果一种基于清除储库的策略与积极的高效抗逆转录病毒治疗(HAART)策略相补充,那么人们相信 HIV 感染的治愈将在短期内实现。

相似文献

1
A Review of Current Strategies Towards the Elimination of Latent HIV-1 and Subsequent HIV-1 Cure.消除潜伏 HIV-1 并随后实现 HIV-1 治愈的当前策略综述。
Curr HIV Res. 2021;19(1):14-26. doi: 10.2174/1570162X18999200819172009.
2
Landscape review of current HIV 'kick and kill' cure research - some kicking, not enough killing.当前艾滋病病毒“踢杀”疗法研究的全景综述——有所进展,但成效不足。
BMC Infect Dis. 2017 Aug 29;17(1):595. doi: 10.1186/s12879-017-2683-3.
3
Block-And-Lock: New Horizons for a Cure for HIV-1.阻断与锁定:治愈HIV-1的新视野
Viruses. 2020 Dec 15;12(12):1443. doi: 10.3390/v12121443.
4
Current views on HIV-1 latency, persistence, and cure.关于人类免疫缺陷病毒1型(HIV-1)潜伏、持续存在及治愈的当前观点。
Folia Microbiol (Praha). 2017 Jan;62(1):73-87. doi: 10.1007/s12223-016-0474-7. Epub 2016 Oct 5.
5
On the way to find a cure: Purging latent HIV-1 reservoirs.在寻找治愈方法的道路上:清除潜伏的HIV-1病毒库。
Biochem Pharmacol. 2017 Dec 15;146:10-22. doi: 10.1016/j.bcp.2017.07.001. Epub 2017 Jul 4.
6
Block and Lock HIV Cure Strategies to Control the Latent Reservoir.阻断和锁定 HIV 治愈策略以控制潜伏库。
Front Cell Infect Microbiol. 2020 Aug 14;10:424. doi: 10.3389/fcimb.2020.00424. eCollection 2020.
7
Strategies to eradicate HIV from infected patients: elimination of latent provirus reservoirs.从感染患者中根除 HIV 的策略:消除潜伏的前病毒库。
Cell Mol Life Sci. 2019 Sep;76(18):3583-3600. doi: 10.1007/s00018-019-03156-8. Epub 2019 May 25.
8
Current and Future Therapeutic Strategies for Lentiviral Eradication from Macrophage Reservoirs.从巨噬细胞储存库中根除慢病毒的当前及未来治疗策略
J Neuroimmune Pharmacol. 2019 Mar;14(1):68-93. doi: 10.1007/s11481-018-9814-5. Epub 2018 Oct 13.
9
From reactivation of latent HIV-1 to elimination of the latent reservoir: the presence of multiple barriers to viral eradication.从潜伏 HIV-1 的再激活到潜伏库的消除:病毒清除存在多种障碍。
Bioessays. 2013 Jun;35(6):544-52. doi: 10.1002/bies.201200170. Epub 2013 Apr 24.
10
The HIV Latency Reversal Agent HODHBt Enhances NK Cell Effector and Memory-Like Functions by Increasing Interleukin-15-Mediated STAT Activation.HIV 潜伏逆转剂 HODHBt 通过增加白细胞介素 15 介导的 STAT 激活增强 NK 细胞效应和记忆样功能。
J Virol. 2022 Aug 10;96(15):e0037222. doi: 10.1128/jvi.00372-22. Epub 2022 Jul 14.

引用本文的文献

1
Integrator complex subunit 12 knockout overcomes a transcriptional block to HIV latency reversal.整合酶复合物亚基12基因敲除克服了HIV潜伏逆转的转录障碍。
Elife. 2025 Apr 10;13:RP103064. doi: 10.7554/eLife.103064.
2
The Role of Sustained Type I Interferon Secretion in Chronic HIV Pathogenicity: Implications for Viral Persistence, Immune Activation, and Immunometabolism.持续性I型干扰素分泌在慢性HIV致病性中的作用:对病毒持续存在、免疫激活和免疫代谢的影响
Viruses. 2025 Jan 22;17(2):139. doi: 10.3390/v17020139.
3
Breaking Barriers to an HIV-1 Cure: Innovations in Gene Editing, Immune Modulation, and Reservoir Eradication.突破治愈HIV-1的障碍:基因编辑、免疫调节和病毒储存库清除方面的创新
Life (Basel). 2025 Feb 11;15(2):276. doi: 10.3390/life15020276.
4
Structural and Functional Studies on HIV Protease: Mechanism of Action, Subtypes, Inhibitors, and Drug Resistance.HIV 蛋白酶的结构与功能研究:作用机制、亚型、抑制剂和耐药性。
Methods Mol Biol. 2025;2867:185-200. doi: 10.1007/978-1-0716-4196-5_11.
5
Integrator complex subunit 12 knockout overcomes a transcriptional block to HIV latency reversal.整合酶复合物亚基12基因敲除克服了HIV潜伏逆转的转录障碍。
bioRxiv. 2025 Feb 19:2024.08.30.610517. doi: 10.1101/2024.08.30.610517.
6
iTRAQ-based proteomic study on monocyte cell model discovered an association of LAMP2 downregulation with HIV-1 latency.基于iTRAQ的单核细胞模型蛋白质组学研究发现LAMP2下调与HIV-1潜伏感染有关。
Proteome Sci. 2024 May 15;22(1):6. doi: 10.1186/s12953-024-00230-3.
7
Single-Cell Single-Molecule RNA-FISH Combined with Immunofluorescence and High-Speed and High-Resolution Scanning Analysis to Visualize the Reactivation of Latent HIV-1.单细胞单分子 RNA-FISH 联合免疫荧光和高速高分辨率扫描分析可视化潜伏 HIV-1 的重新激活。
Methods Mol Biol. 2024;2807:45-59. doi: 10.1007/978-1-0716-3862-0_4.
8
Breaking the Silence: Regulation of HIV Transcription and Latency on the Road to a Cure.打破沉默:治愈艾滋病道路上的 HIV 转录和潜伏期调控。
Viruses. 2023 Dec 15;15(12):2435. doi: 10.3390/v15122435.
9
Nucleoside Analog 2',3'-Isopropylidene-5-Iodouridine as Novel Efficient Inhibitor of HIV-1.核苷类似物2',3'-异亚丙基-5-碘尿苷作为新型高效的HIV-1抑制剂
Pharmaceutics. 2023 Sep 27;15(10):2389. doi: 10.3390/pharmaceutics15102389.
10
Human immunodeficiency virus and antiretroviral therapy-mediated immune cell metabolic dysregulation in children born to HIV-infected women: potential clinical implications.人类免疫缺陷病毒和抗逆转录病毒治疗介导的感染 HIV 妇女所生儿童免疫细胞代谢失调:潜在的临床意义。
Front Immunol. 2023 Jun 7;14:1182217. doi: 10.3389/fimmu.2023.1182217. eCollection 2023.

本文引用的文献

1
Evidence for HIV-1 cure after CCR5Δ32/Δ32 allogeneic haemopoietic stem-cell transplantation 30 months post analytical treatment interruption: a case report.抗逆转录病毒治疗中断 30 个月后 CCR5Δ32/Δ32 异基因造血干细胞移植治疗 HIV-1 治愈的证据:一例报告。
Lancet HIV. 2020 May;7(5):e340-e347. doi: 10.1016/S2352-3018(20)30069-2. Epub 2020 Mar 10.
2
Systemic HIV and SIV latency reversal via non-canonical NF-κB signalling in vivo.体内通过非典型 NF-κB 信号逆转系统性 HIV 和 SIV 的潜伏。
Nature. 2020 Feb;578(7793):160-165. doi: 10.1038/s41586-020-1951-3. Epub 2020 Jan 22.
3
Robust and persistent reactivation of SIV and HIV by N-803 and depletion of CD8 cells.N-803 诱导的 SIV 和 HIV 持久而稳健的再激活和 CD8 细胞耗竭。
Nature. 2020 Feb;578(7793):154-159. doi: 10.1038/s41586-020-1946-0. Epub 2020 Jan 22.
4
CRISPR/Cas system: An emerging technology in stem cell research.CRISPR/Cas系统:干细胞研究中的一项新兴技术。
World J Stem Cells. 2019 Nov 26;11(11):937-956. doi: 10.4252/wjsc.v11.i11.937.
5
Designer Nucleases: Gene-Editing Therapies using CCR5 as an Emerging Target in HIV.设计核酸酶:以CCR5为新兴靶点治疗HIV的基因编辑疗法
Curr HIV Res. 2019;17(5):306-323. doi: 10.2174/1570162X17666191025112918.
6
Latency reversal agents affect differently the latent reservoir present in distinct CD4+ T subpopulations.潜伏逆转剂对不同 CD4+ T 亚群中存在的潜伏储库的影响不同。
PLoS Pathog. 2019 Aug 19;15(8):e1007991. doi: 10.1371/journal.ppat.1007991. eCollection 2019 Aug.
7
Deep latency: A new insight into a functional HIV cure.深度潜伏:功能性 HIV 治愈的新见解。
EBioMedicine. 2019 Jul;45:624-629. doi: 10.1016/j.ebiom.2019.06.020. Epub 2019 Jun 18.
8
Cerebral Vascular Toxicity of Antiretroviral Therapy.抗逆转录病毒治疗的脑血管毒性。
J Neuroimmune Pharmacol. 2021 Mar;16(1):74-89. doi: 10.1007/s11481-019-09858-x. Epub 2019 Jun 17.
9
Corrigendum to "A Critical Review of the Evidence Concerning the HIV Latency Reversing Effect of Disulfiram, the Possible Explanations for Its Inability to Reduce the Size of the Latent Reservoir In Vivo, and the Caveats Associated with Its Use in Practice".《关于双硫仑对HIV潜伏逆转作用的证据的批判性综述、其在体内无法缩小潜伏库规模的可能解释以及与实际应用相关的注意事项》勘误
AIDS Res Treat. 2019 Mar 13;2019:4942573. doi: 10.1155/2019/4942573. eCollection 2019.
10
HIV "cure": A shot in the arm?HIV“治愈”:一针见效?
EBioMedicine. 2019 Apr;42:3-5. doi: 10.1016/j.ebiom.2019.04.011. Epub 2019 Apr 11.